HOPE open-label study of vaginal ring for preventing HIV begins for former ASPIRE participants

Used consistently, monthly vaginal ring may be highly effective against HIV in women, suggest new analyses from ASPIRE

International Study Finds Rectal Microbicide Gel Safe When Used Daily and With Sex

Dapivirine vaginal ring helped protect women against HIV in ASPIRE Phase III trial

Microbicide Trials Network researchers bring current and emerging issues in HIV prevention to the forefront at IAS 2015

Researchers complete ASPIRE Phase III trial of the dapivirine vaginal ring for HIV prevention in women

Final results of the HIV prevention study VOICE are published in NEJM

Women who took part in VOICE study speak up about why they didn’t use the HIV prevention products being tested

New results from VOICE associates tenofovir gel use with lower HSV-2 risk in women

ASPIRE Phase III trial of a vaginal ring for HIV prevention completes enrollment of 2,629 women